FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
Milestones in Diabetes
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
IHME reported global diabetes cases to soar from 529 million to 1.3 billion by 2050
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
U.S. FDA approved new class of medicines to treat pediatric type 2 diabetes
On Jun. 20, 2023, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim’s Jardiance (empagliflozin) and Synjardy…
Biotechnology | Diagnostics | Genomics | NIH | Therapeutics
Large-scale genetic analysis showed microRNAs in human pancreas associated with diabetes
On Feb. 9, 2023, the National Institutes of Health (NIH) announced that a new large-scale genetic analysis found…
Biotechnology | Disease | FDA | Therapeutics
FDA approved first drug that can delay onset of Type 1 Diabetes
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…
Researchers identified a pathway by which chronic hyperglycaemia reduces cell function
On Nov. 14, 2022, researchers discovered the pathway by which chronic hyperglycaemia reduces β-cell function. Their data also…
Benaroya Research Institute received $11.4 million to explore link between viruses and immune system diseases
On Jun. 17, 2022, Benaroya Research Institute at Virginia Mason (BRI) announced a 5-year, $11.4 million grant from…
International team createed first complete fruit fly cell atlas
On Mar. 9, 2022, Harvard Medical School announced that an international research team had completed an atlas of…
Vibativ effectively helped treat secondary bacterial infections in COVID-19 patients
On Jun. 21, 2021, Cumberland Pharma released a series of case reports describing the effectiveness of Vibativ (telavancin)…
FDA approved new rug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
COVID-19 | Diagnostics | Disease | NIH | Women's Health
Severe COVID-19 in pregnancy associated with preterm birth, other complications
On Jan. 28, 2021, National Institutes of Health (NIH) researchers reported that pregnant women who experienced severe symptoms…
FDA approved first generic of drug used to treat severe hypoglycemia
On Dec. 28, 2020, the FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged…
NIH funded first nationwide network to study rare forms of diabetes
On Sept. 30, 2020, the NIH announced funding of a nationwide study to discover the cause of several…
NIH awarded $95 million for Einstein-Mount Sinai Diabetes Research Center
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
Philips and BioIntelliSense formed strategic collaboration to enhance remote patient monitoring at home
On Jul. 9, 2020, Royal Philips announced it had formed a strategic collaboration with BioIntelliSense, a continuous health…
Carl Wesolowski discovered that metformin stays in the body for a lengthy period of time if delivered intravenously.
On Apr. 9, 2020, Dr. Carl Wesolowski at the University of Saskatchewan discovered that metformin, often used to…
Abbott FreeStyleﾮ Libre 14 Day System available in US for hospitalized patients with diabetes during COVID-19 pandemic
On Apr. 8, 2020, Abbott announced that the FreeStyle Libre 14 day system, a continuous glucose monitoring (CGM)…
Artificial intelligence yielded new antibiotic
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
Vanderbilt University Medical Center researchers announced new insight on diabetic retinopathy
On Jan. 23, 2020, Vanderbilt University Medical Center researchers Megan Capozzi, PhD, John Penn, PhD, and colleagues showed…
Government of Canada and partners invested $18 million in crucial microbiome research
On Jan. 30, 2019, the Government of Canada announced an investment of $18 million over five years in…
USC scientists launched global effort to find the next diabetes drug
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
Ozempic (semaglutide) was approved in the U.S.
On Dec. 5, 2017, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Ozempic…
Canada Foundation awarded $6 million for Innovation Metabolomics Innovation Centre at the University of Alberta
On Jan. 9, 2017, the Canada Foundation for Innovation (CFI) awarded $6 million for Canada’s national metabolomics laboratory,…
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
Biotechnology | Diagnostics | Disease | NIH | Therapeutics
The McDonnell Genome Institute received a $60 million from the NIH to study the genetics of common diseases
On Jan. 19, 2016, the McDonnell Genome Institute at Washington University School of Medicine in St. Louis announced…
Benaroya Research Institute’s Carla J Greenbaum, MD was named chair of Type 1 Diabetes TrialNet
On Jul. 14, 2015, Benaroya Research Institute at Virginia Mason (BRI) announced that Carla J. Greenbaum, MD, had…
FDA approved Novo Nordisk’s injection for obesity
On Dec. 23, 2014, Novo Nordisk the FDA approved a formulation of Novo Nordiskﾒs diabetes drug, liraglutide, for…
The University of Iowa dedicated $126 million biomedical hub
On Oct. 15, 2014, the University of Iowa ushered in a new age of accelerated research in biomedicine…